CEACAM5 and neoplasm: To determine the immune cell subset(s) involved in MC32A tumor rejection following vaccine + mGITRL-FP treatment, CEA.Tg mice were administered depleting antibodies for CD4, CD8, or NK cells (Figure 6C) and depletion was confirmed by flow cytometry (Supplementary Figures 1 and 2).